| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2874680 | The Annals of Thoracic Surgery | 2015 | 7 Pages |
Abstract
LCNEC is a rare neuroendocrine pulmonary malignancy that is associated with poor prognosis and high recurrence rates. Surgical treatment can achieve satisfactory results in selected cases. Neuroendocrine marker profiles may predict prognosis and may influence the decision for adjuvant therapy or follow-up intervals.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Florian MD, Hendrik MD, PhD, Thomas MD, Arne MD, Hans MD, PhD,